迪安诊断
(300244)
| 流通市值：102.90亿 | | | 总市值：128.25亿 |
| 流通股本：5.01亿 | | | 总股本：6.25亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 4,773,379,012.31 | 2,246,960,355.26 | 10,096,031,634.52 | 7,565,586,728.42 |
| 营业收入 | 4,773,379,012.31 | 2,246,960,355.26 | 10,096,031,634.52 | 7,565,586,728.42 |
| 二、营业总成本 | 4,307,402,237.14 | 2,058,243,891.81 | 9,550,980,754.99 | 7,011,768,898.52 |
| 营业成本 | 3,335,614,256.64 | 1,584,708,129.03 | 7,222,145,881.9 | 5,366,020,438.92 |
| 税金及附加 | 20,507,184.48 | 11,956,598.49 | 43,334,862.99 | 31,024,282.69 |
| 销售费用 | 489,186,338.83 | 239,114,285.96 | 1,158,888,351.57 | 830,833,984.8 |
| 管理费用 | 300,160,322.12 | 137,929,119.54 | 715,468,670.26 | 518,131,891.35 |
| 研发费用 | 96,344,209.22 | 50,731,145.99 | 254,541,633.24 | 169,463,374.03 |
| 财务费用 | 65,589,925.85 | 33,804,612.8 | 156,601,355.03 | 96,294,926.73 |
| 其中:利息费用 | 62,601,065.18 | 32,742,408.12 | 161,458,593.11 | 108,922,186.26 |
| 其中:利息收入 | 6,158,728.54 | 4,376,482.14 | 24,344,435.43 | 23,153,384.53 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -3,941,717.7 | 2,107,185.2 | 3,527,739.17 | 11,493,333.82 |
| 加:投资收益 | 420,277.21 | -11,473,470.7 | 26,194,138.84 | 13,340,411.44 |
| 资产处置收益 | -679,437.27 | 592,162.41 | -182,538.26 | -631,731.09 |
| 资产减值损失(新) | -3,920,608.36 | -1,052,374.98 | -96,289,124.65 | 720,414.73 |
| 信用减值损失(新) | -22,397,308.7 | -28,859,298.77 | -236,816,653.52 | -317,477,767.23 |
| 其他收益 | 11,211,195.02 | 6,697,037.22 | 39,830,920.4 | 23,767,240.13 |
| 四、营业利润 | 446,669,175.37 | 156,727,703.83 | 281,315,361.51 | 285,029,731.7 |
| 加:营业外收入 | 987,964.12 | 435,551.13 | 5,106,231.23 | 3,708,717.82 |
| 减:营业外支出 | 12,591,233 | 2,481,134.43 | 30,231,772.11 | 12,649,316.3 |
| 五、利润总额 | 435,065,906.49 | 154,682,120.53 | 256,189,820.63 | 276,089,133.22 |
| 减:所得税费用 | 114,339,975.3 | 50,466,132.64 | 110,583,583.78 | 94,078,295.92 |
| 六、净利润 | 320,725,931.19 | 104,215,987.89 | 145,606,236.85 | 182,010,837.3 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 320,725,931.19 | 104,215,987.89 | 145,606,236.85 | 182,010,837.3 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 232,354,793.03 | 64,374,317.59 | 44,052,664.1 | 56,704,839.25 |
| 少数股东损益 | 88,371,138.16 | 39,841,670.3 | 101,553,572.75 | 125,305,998.05 |
| 扣除非经常损益后的净利润 | 238,792,780.76 | 61,979,531.23 | 11,839,376.79 | 35,551,854.51 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.38 | 0.11 | 0.07 | 0.09 |
| (二)稀释每股收益 | 0.38 | 0.11 | 0.07 | 0.09 |
| 九、综合收益总额 | 320,725,931.19 | 104,215,987.89 | 145,606,236.85 | 182,010,837.3 |
| 归属于母公司股东的综合收益总额 | 232,354,793.03 | 64,374,317.59 | 44,052,664.1 | 56,704,839.25 |
| 归属于少数股东的综合收益总额 | 88,371,138.16 | 39,841,670.3 | 101,553,572.75 | 125,305,998.05 |
| 公告日期 | 2026-08-21 | 2026-04-28 | 2026-04-22 | 2025-10-24 |
| 审计意见(境内) | | | 标准无保留意见 | |